A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Several experts said the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or prison.
Service Reaction and Material Removal
According to TikTok, the service has taken down problematic material and banned related keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within moments of joining one community, a vendor posted contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Pricing
Inside these groups, messages display black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially serious health risks”.
